Patent ID: 6287598
Filing Date: 2001-09-11
Classification: A61K

Abstract:
A method for administering an antiepileptic drug to the gastrointestinal tract of humans, wherein the method comprises:(a) admitting orally into the human a dosage form comprising 10 nanograms to 750 milligrams of an antiepileptic drug selected from the group consisting of valproic acid, valproic acid salts, sodium valproate, potassium valproate, calcium valproate, valpromide, valproic ester, divalproex sodium, oligomer salt of valproic acid, prodrug of valproic acid, and pharmaceutically acceptable derivatives of valproic acid; which drug possessing antiepileptic therapy is administered from a dosage form comprising a member selected from the group consisting of a sustained-release dosage form and a controlled-release dosage form; and,(b) administering the antiepileptic drug from the dosage form over a therapeutic dose up to 750 mg over an extended period of time up to 30 hours to provide the antiepileptic therapy.